Not applicableLooking for participantsNCT05846763
What this trial is testing
Obinutuzumab in Combination With Lenalidomide in Relapsed or Refractory Follicular Lymphoma in Real World Study
Who this might be right for
Follicular Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 50